世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032539

ヘパリン市場規模、シェア、動向分析レポート、予測2022-2030

Grand View Research Inc.

Heparin Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2022 - 2030

発刊日 2022/07

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000032539

Individual
Team
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

ヘパリン市場の規模、シェア、動向分析レポート:種類別(低分子量ヘパリン、未分画ヘパリン)、投与経路別、用途別、最終用途別、供給元別、地域別、およびグメント予測、2022〜2030

レポートの概要
世界のヘパリン市場の規模は2021年に73億ドルと評価され、2022年から2030年までに2.4%のCAGRが見込まれます。腎機能障害、冠状動脈疾患、静脈血栓塞栓症などの有病率の増加が市場をけん引すると予想されます。2022年のCDCによると、米国では毎年約90万人が静脈血栓塞栓症に罹患し、診断から1か月以内に10%〜30%の人が死亡する可能性があります。

レポート詳細

目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights

Chapter 3 Heparin Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of chronic diseases
3.2.1.2 Growing demand for whole blood and blood components transfusion
3.2.1.3 Increasing geriatric population
3.2.1.4 High usage of plasma in the pharmaceutical industry
3.2.2 Market restraint analysis
3.2.2.1 Risk of blood-transmitted diseases and an increasing number of blood substitutes
3.2.2.2 Emerging oral anticoagulants
3.3 Penetration & Growth Prospect Mapping
3.4 Heparin: Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis

Chapter 4 Heparin Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Heparin Market, by Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Low Molecular Weight Heparin (LMWH)
4.5.1.1 Low molecular weight heparin market, 2018 - 2030 (USD Million)
4.5.2 Ultra-Low Molecular Weight Heparin (ULMWH)
4.5.2.1 Ultra-Low molecular weight heparin market, 2018 - 2030 (USD Million)
4.5.3 Unfractionated Heparin
4.5.3.1 Unfractionated heparin market, 2018 - 2030 (USD Million)

Chapter 5 Heparin Market Segment Analysis, By Route of Administration, 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Route of Administration Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Heparin Market, by Route of Administration, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Intravenous
5.5.1.1 Intravenous market, 2018 - 2030 (USD Million)
5.5.2 Subcutaneous
5.5.2.1 Subcutaneous market, 2018 - 2030 (USD Million)

Chapter 6 Heparin Market Segment Analysis, By Application, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Heparin Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Venous Thromboembolism
6.5.1.1 Venous thromboembolism market, 2018 - 2030 (USD Million)
6.5.2 Coronary Artery Disease
6.5.2.1 Coronary artery disease market, 2018 - 2030 (USD Million)
6.5.3 Renal Impairment
6.5.3.1 Renal impairment market, 2018 - 2030 (USD Million)
6.5.4 Atrial Fibrillation
6.5.4.1 Atrial fibrillation market, 2018 - 2030 (USD Million)
6.5.5 Others
6.5.5.1 Others market, 2018 - 2030 (USD Million)

Chapter 7 Heparin Market Segment Analysis, By End-use, 2018 - 2030 (USD Million)
7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global Heparin Market, by End-use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Outpatient
7.5.1.1 Outpatient market, 2018 - 2030 (USD Million)
7.5.2 Inpatient
7.5.2.1 Inpatient market, 2018 - 2030 (USD Million)

Chapter 8 Heparin Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
8.1 Definition and Scope
8.2 Source Market Share Analysis, 2021 & 2030
8.3 Segment Dashboard
8.4 Global Heparin Market, by Source, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
8.5.1 Porcine
8.5.1.1 Porcine market, 2018 - 2030 (USD Million)
8.5.2 Bovine
8.5.2.1 Bovine market, 2018 - 2030 (USD Million)
8.5.3 Others
8.5.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 9 Heparin Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2021 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 SWOT Analysis
9.5.1 North America
9.5.2 Europe
9.5.3 Asia Pacific
9.5.4 Latin America
9.5.5 Middle East and Africa
9.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
9.6.1 North America
9.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
9.6.1.2 U.S.
9.6.1.2.1 U.S. heparin market, 2018 - 2030 (USD Million)
9.6.1.3 Canada
9.6.1.3.1 Canada heparin market, 2018 - 2030 (USD Million)
9.6.2 Europe
9.6.2.1 Europe heparin market, 2018 - 2030 (USD Million)
9.6.2.2 U.K.
9.6.2.2.1 U.K. heparin market, 2018 - 2030 (USD Million)
9.6.2.3 Germany
9.6.2.3.1 Germany heparin market, 2018 - 2030 (USD Million)
9.6.2.4 Spain
9.6.2.4.1 Spain heparin market, 2018 - 2030 (USD Million)
9.6.2.5 France
9.6.2.5.1 France heparin market, 2018 - 2030 (USD Million)
9.6.2.6 Italy
9.6.2.6.1 Italy heparin market, 2018 - 2030 (USD Million)
9.6.2.7 Russia
9.6.2.7.1 Russia heparin market, 2018 - 2030 (USD Million)
9.6.3 Asia Pacific
9.6.3.1 Asia Pacific heparin market, 2018 - 2030 (USD Million)
9.6.3.2 Japan
9.6.3.2.1 Japan heparin market, 2018 - 2030 (USD Million)
9.6.3.3 China
9.6.3.3.1 China heparin market, 2018 - 2030 (USD Million)
9.6.3.4 India
9.6.3.4.1 India heparin market, 2018 - 2030 (USD Million)
9.6.3.5 South Korea
9.6.3.5.1 South Korea heparin market, 2018 - 2030 (USD Million)
9.6.3.6 Australia
9.6.3.6.1 Australia heparin market, 2018 - 2030 (USD Million)
9.6.3.7 Singapore
9.6.3.7.1 Singapore heparin market, 2018 - 2030 (USD Million)
9.6.4 Latin America
9.6.4.1 Latin America heparin market, 2018 - 2030 (USD Million)
9.6.4.2 Brazil
9.6.4.2.1 Brazil heparin market, 2018 - 2030 (USD Million)
9.6.4.3 Mexico
9.6.4.3.1 Mexico heparin market, 2018 - 2030 (USD Million)
9.6.4.4 Argentina
9.6.4.4.1 Argentina heparin market, 2018 - 2030 (USD Million)
9.6.5 MEA
9.6.5.1 MEA heparin market, 2018 - 2030 (USD Million)
9.6.5.2 South Africa
9.6.5.2.1 South Africa heparin market, 2018 - 2030 (USD Million)
9.6.5.3 Saudi Arabia
9.6.5.3.1 Saudi Arabia heparin market, 2018 - 2030 (USD Million)
9.6.5.4 UAE
9.6.5.4.1 UAE heparin market, 2018 - 2030 (USD Million)

Chapter 10 Heparin Market - Competitive Analysis
10.1 Recent Developments & Impact Analysis, by Key Market Participants
10.1.1 Ansoff matrix
10.1.2 Heat map analysis
10.1.3 Major Deals and Strategic Alliances Analysis
10.1.3.1 Joint Ventures
10.1.3.2 Licensing Agreements
10.1.3.3 Product Launches
10.1.3.4 Conferences and Campaigns
10.2 Company Categorization
10.2.1 Innovators
10.2.2 Market Leaders
10.3 Vendor Landscape
10.3.1 List of key distributors and channel partners
10.3.2 Key customers
10.4 Public Companies
10.4.1 Competitive Dashboard Analysis
10.4.2 Market Differentiators
10.5 Private Companies
10.5.1 List of key emerging companies
10.6 Company Profiles
10.6.1 GlaxoSmithKline plc (GSK)
10.6.1.1 Company overview
10.6.1.2 Financial performance
10.6.1.3 Product benchmarking
10.6.1.4 Strategic Initiatives
10.6.2 Pfizer Inc.
10.6.2.1 Company overview
10.6.2.2 Financial performance
10.6.2.3 Product benchmarking
10.6.2.4 Strategic Initiatives
10.6.3 LEO Pharma A/S
10.6.3.1 Company overview
10.6.3.2 Financial performance
10.6.3.3 Product benchmarking
10.6.3.4 Strategic Initiatives
10.6.4 Sanofi
10.6.4.1 Company overview
10.6.4.2 Financial performance
10.6.4.3 Product benchmarking
10.6.4.4 Strategic Initiatives
10.6.5 Dr. Reddy’s Laboratories Ltd.
10.6.5.1 Company overview
10.6.5.2 Financial performance
10.6.5.3 Product benchmarking
10.6.5.4 Strategic Initiatives
10.6.6 Aspen Holdings
10.6.6.1 Company overview
10.6.6.2 Financial performance
10.6.6.3 Product benchmarking
10.6.6.4 Strategic Initiatives
10.6.7 B. Braun Medical Inc.
10.6.7.1 Company overview
10.6.7.2 Financial performance
10.6.7.3 Product benchmarking
10.6.7.4 Strategic initiatives
10.6.8 Fresenius SE & Co. KGaA
10.6.8.1 Company overview
10.6.8.2 Financial performance
10.6.8.3 Product benchmarking
10.6.8.4 Strategic initiatives
10.6.9 Sandoz (Novartis AG)
10.6.9.1 Company overview
10.6.9.2 Financial performance
10.6.9.3 Product benchmarking
10.6.9.4 Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Leading market players anticipated witnessing highest growth
Table 4 Global Heparin Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 7 Global Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 8 Global Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 9 Global Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 10 North America Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 12 North America Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 13 North America Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 14 North America Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 15 North America Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 16 U.S. Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 17 U.S. Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 18 U.S. Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 U.S. Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 20 U.S. Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 21 Canada Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 22 Canada Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 23 Canada Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 24 Canada Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 25 Canada Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 26 Europe Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 27 Europe Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 28 Europe Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 29 Europe Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 Europe Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Europe Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 32 Germany Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 33 Germany Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 34 Germany Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 Germany Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 36 Germany Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 37 U.K. Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 38 U.K. Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 39 U.K. Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 40 U.K. Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 41 U.K. Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 42 France Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 43 France Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 44 France Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 45 France Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 46 France Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 47 Italy Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 48 Italy Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 49 Italy Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Italy Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 51 Italy Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 52 Spain Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 53 Spain Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 54 Spain Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 Spain Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 56 Spain Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 57 Russia Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 58 Russia Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 59 Russia Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 60 Russia Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 61 Russia Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 68 Japan Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 69 Japan Heparin Market, By Application 2018 - 2030 (USD Million)
Table 70 Japan Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 Japan Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 72 Japan Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 73 China Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 74 China Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 75 China Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 China Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 77 China Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 78 India Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 79 India Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 80 India Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 81 India Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 82 India Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 83 Australia Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 84 Australia Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 85 Australia Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 Australia Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 87 Australia Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 88 Singapore Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 89 Singapore Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 90 Singapore Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Singapore Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 92 Singapore Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 93 South Korea Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 94 South Korea Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 95 South Korea Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 South Korea Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 97 South Korea Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 98 Latin America Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 99 Latin America Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 100 Latin America Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 101 Latin America Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 102 Latin America Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 103 Latin America Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 104 Brazil Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 105 Brazil Heparin Market, By Application 2018 - 2030 (USD Million)
Table 106 Brazil Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 107 Brazil Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 108 Brazil Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 109 Mexico Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 110 Mexico Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 111 Mexico Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 112 Mexico Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 113 Mexico Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 114 Argentina Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 115 Argentina Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 116 Argentina Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 Argentina Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 118 Argentina Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 119 Middle East & Africa Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 120 Middle East & Africa Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 121 Middle East & Africa Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 122 Middle East & Africa Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 123 Middle East & Africa Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 124 Middle East & Africa Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 126 Saudi Arabia Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 127 Saudi Arabia Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 128 Saudi Arabia Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 129 Saudi Arabia Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 130 South Africa Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 131 South Africa Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 132 South Africa Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 133 South Africa Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 134 South Africa Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 135 UAE Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 136 UAE Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 137 UAE Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 138 UAE Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 139 UAE Heparin Market, By Source, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Heparin market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2020)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Heparin market: type movement analysis
Fig. 17 Heparin market: type segment dashboard
Fig. 18 Heparin market type outlook: Key takeaways
Fig. 19 Low molecular weight heparin market, 2018 - 2030 (USD Million)
Fig. 20 Ultra-Low molecular weight heparin market, 2018 - 2030 (USD Million)
Fig. 21 Unfractionated heparin market, 2018 - 2030 (USD Million)
Fig. 22 Heparin market: route of administration movement analysis
Fig. 23 Heparin market: route of administration segment dashboard
Fig. 24 Heparin market dosage form outlook: Key takeaways
Fig. 25 Intravenous market, 2018 - 2030 (USD Million)
Fig. 26 Subcutaneous market, 2018 - 2030 (USD Million)
Fig. 27 Heparin market: application movement analysis
Fig. 28 Heparin market: application segment dashboard
Fig. 29 Heparin market application outlook: Key takeaways
Fig. 30 Venous thromboembolism market, 2018 - 2030 (USD Million)
Fig. 31 Coronary artery disease market, 2018 - 2030 (USD Million)
Fig. 32 Renal impairment market, 2018 - 2030 (USD Million)
Fig. 33 Atrial fibrillation market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Heparin market: end-use movement analysis
Fig. 36 Heparin market: end-use segment dashboard
Fig. 37 Heparin market end-use outlook: Key takeaways
Fig. 38 Outpatient market, 2018 - 2030 (USD Million)
Fig. 39 Inpatient market, 2018 - 2030 (USD Million)
Fig. 40 Heparin market: source movement analysis
Fig. 41 Heparin market: source segment dashboard
Fig. 42 Heparin market source outlook: Key takeaways
Fig. 43 Porcine market, 2018 - 2030 (USD Million)
Fig. 44 Bovine market, 2018 - 2030 (USD Million)
Fig. 45 Others market, 2018 - 2030 (USD Million)
Fig. 46 Regional outlook, 2021 & 2030
Fig. 47 Regional market dashboard
Fig. 48 Regional marketplace: Key takeaways
Fig. 49 North America, SWOT
Fig. 50 Europe, SWOT
Fig. 51 Asia Pacific, SWOT
Fig. 52 Latin America, SWOT
Fig. 53 Middle East and Africa, SWOT
Fig. 54 North America
Fig. 55 North America heparin market, 2018 - 2030 (USD Million)
Fig. 56 U.S.
Fig. 57 U.S. heparin market, 2018 - 2030 (USD Million)
Fig. 58 Canada
Fig. 59 Canada heparin market, 2018 - 2030 (USD Million)
Fig. 60 Europe
Fig. 61 Europe heparin market, 2018 - 2030 (USD Million)
Fig. 62 U.K.
Fig. 63 U.K. heparin market, 2018 - 2030 (USD Million)
Fig. 64 Germany
Fig. 65 Germany heparin market, 2018 - 2030 (USD Million)
Fig. 66 Spain
Fig. 67 Spain heparin market, 2018 - 2030 (USD Million)
Fig. 68 France
Fig. 69 France heparin market, 2018 - 2030 (USD Million)
Fig. 70 Italy
Fig. 71 Italy heparin market, 2018 - 2030 (USD Million)
Fig. 72 Russia
Fig. 73 Russia heparin market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific heparin market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan heparin market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China heparin market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India heparin market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea heparin market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia heparin market, 2018 - 2030 (USD Million)
Fig. 86 Singapore
Fig. 87 Singapore heparin market, 2018 - 2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America heparin market, 2018 - 2030 (USD Million)
Fig. 90 Brazil
Fig. 91 Brazil heparin market, 2018 - 2030 (USD Million)
Fig. 92 Mexico
Fig. 93 Mexico heparin market, 2018 - 2030 (USD Million)
Fig. 94 Argentina
Fig. 95 Argentina heparin market, 2018 - 2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA heparin market, 2018 - 2030 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa heparin market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia heparin market, 2018 - 2030 (USD Million)
Fig. 102 UAE
Fig. 103 UAE heparin market, 2018 - 2030 (USD Million)
Fig. 104 Ansoff Matrix
Fig. 105 Heat map analysis
Fig. 106 Market differentiators

この商品のレポートナンバー

0000032539

TOP